Difficulty: Medium
Average Score: 64%
Practice
The cut off number of transfused blood units to start an iron chelating agent in chronic hemolytic anemia patients is:
Correct answer
B
Rationale
The correct answer is B) 8-10 times for starting an iron chelating agent in chronic hemolytic anemia patients. In pediatric patients with chronic hemolytic anemia, such as sickle cell disease, regular blood transfusions can lead to iron overload due to the iron content in transfused blood. Iron chelation therapy helps in removing excess iron from the body to prevent organ damage.
Option A) 5-7 times is incorrect because patients usually require a higher number of transfusions before initiating iron chelation therapy to effectively manage iron overload.
Option C) 12-15 times and Option D) 15-20 times are incorrect as they suggest waiting for a significantly higher number of transfusions before starting iron chelation therapy. Delaying the initiation of chelation therapy can increase the risk of iron-related complications in these patients.
In an educational context, understanding the appropriate timing for starting iron chelation therapy in pediatric patients with chronic hemolytic anemia is crucial for preventing long-term complications associated with iron overload. Nurses caring for these patients need to be aware of the guidelines regarding the initiation of chelation therapy based on the number of transfusions received, as highlighted in this question. This knowledge is essential for providing safe and effective care to pediatric patients with chronic hemolytic anemia.
Option A) 5-7 times is incorrect because patients usually require a higher number of transfusions before initiating iron chelation therapy to effectively manage iron overload.
Option C) 12-15 times and Option D) 15-20 times are incorrect as they suggest waiting for a significantly higher number of transfusions before starting iron chelation therapy. Delaying the initiation of chelation therapy can increase the risk of iron-related complications in these patients.
In an educational context, understanding the appropriate timing for starting iron chelation therapy in pediatric patients with chronic hemolytic anemia is crucial for preventing long-term complications associated with iron overload. Nurses caring for these patients need to be aware of the guidelines regarding the initiation of chelation therapy based on the number of transfusions received, as highlighted in this question. This knowledge is essential for providing safe and effective care to pediatric patients with chronic hemolytic anemia.